Bros. Advisors Lp Baker's Net Worth
Bros. Advisors Lp Baker's net worth is estimated to be at least $2,593,055,947.22 as of 11/22/2024. CoreStreet's estimation of Bros. Advisors Lp Baker's net worth is based on their sale of stock and current holding of stock.
Bros. Advisors Lp Baker is Director at IGM Biosciences Inc. They have executed at least 106 trades of stock as per SEC Form 4 filings. Their most recent trade was for 97,473 units of IGMS stock on 03/28/2024. Their biggest sale was on 05/08/2020 when they sold 500,000 units of Seagen Inc stock for $79,250,000.00. They typically trade 8 times per year.
Total value of insider buys:
- $2,351,757,998.72
Total value of insider sells:
- $241,297,948.50
Most recent insider trade:
- March 28, 2024
Bros. Advisors Lp Baker's Insider Trading History
| IGM Biosciences Inc | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
March 28, 2024 | Director | 97,473 | $9.62 | Buy | $937,690.26 |
March 26, 2024 | Director | 270,000 | $8.26 | Buy | $2,230,200.00 |
Dec. 15, 2023 | Director | 288,007 | $6.55 | Buy | $1,886,445.85 |
Dec. 13, 2023 | Director | 87,316 | $5.96 | Buy | $520,403.36 |
Sept. 20, 2019 | Director | 3,144,000 | $16.00 | Buy | $50,304,000.00 |
| Madrigal Pharmaceuticals Inc | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
Dec. 13, 2023 | Director | 81,159 | $219.39 | Buy | $17,805,473.01 |
Nov. 21, 2023 | Director | 64,350 | $188.47 | Buy | $12,128,044.50 |
Nov. 17, 2023 | Director | 46,370 | $174.70 | Buy | $8,100,839.00 |
Nov. 14, 2023 | Director | 34,188 | $156.42 | Buy | $5,347,686.96 |
| Atreca Inc | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
Oct. 19, 2023 | Major Shareholder | 274,739 | $0.40 | Sell | $109,895.60 |
| Neoleukin Therapeutics | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
Aug. 17, 2023 | Director | 166,942 | $0.69 | Buy | $115,189.98 |
Aug. 15, 2023 | Director | 1,888,800 | $0.63 | Buy | $1,189,944.00 |
July 7, 2020 | Director | 424,000 | $15.25 | Buy | $6,466,000.00 |
Dec. 20, 2019 | Director | 3,017,542 | $8.40 | Buy | $25,347,352.80 |
Aug. 7, 2019 | Director | 371,525 | $3.00 | Buy | $1,114,575.00 |
| ACADIA Pharmaceuticals Inc | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
May 23, 2023 | Director | 209,053 | $25.41 | Buy | $5,312,036.73 |
March 18, 2020 | Director | 1,050,000 | $33.30 | Buy | $34,965,000.00 |
March 16, 2020 | Director | 694,303 | $31.51 | Buy | $21,877,487.53 |
Sept. 20, 2019 | Director | 1,562,500 | $40.00 | Buy | $62,500,000.00 |
Nov. 30, 2018 | Director | 11,764,705 | $17.00 | Buy | $199,999,985.00 |
Sept. 20, 2018 | Director | 1,210,776 | $18.70 | Buy | $22,641,511.20 |
Aug. 10, 2016 | Director | 1,303,030 | $33.00 | Buy | $42,999,990.00 |
April 1, 2016 | Director | 1,449,090 | $27.08 | Buy | $39,241,357.20 |
March 5, 2014 | Director | 526,316 | $28.50 | Buy | $15,000,006.00 |
| Kodiak Sciences Inc | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
June 6, 2022 | Director | 303,917 | $7.77 | Buy | $2,361,435.09 |
June 2, 2022 | Director | 166,232 | $7.67 | Buy | $1,274,999.44 |
May 18, 2022 | Director | 223,766 | $5.97 | Buy | $1,335,883.02 |
May 16, 2022 | Director | 122,100 | $5.72 | Buy | $698,412.00 |
Feb. 17, 2022 | Director | 300,000 | $54.56 | Buy | $16,368,000.00 |
Feb. 15, 2022 | Director | 5,800 | $54.16 | Buy | $314,128.00 |
Jan. 31, 2022 | Director | 30,148 | $57.22 | Buy | $1,725,068.56 |
Jan. 27, 2022 | Director | 262,259 | $51.76 | Buy | $13,574,525.84 |
Jan. 24, 2022 | Director | 362,197 | $57.72 | Buy | $20,906,010.84 |
Jan. 21, 2022 | Director | 133,414 | $56.80 | Buy | $7,577,915.20 |
Sept. 30, 2021 | Director | 86,932 | $95.83 | Buy | $8,330,693.56 |
Sept. 15, 2021 | Director | 30,685 | $94.39 | Buy | $2,896,357.15 |
Sept. 7, 2021 | Director | 57,501 | $93.31 | Buy | $5,365,418.31 |
Aug. 19, 2021 | Director | 83,648 | $87.56 | Buy | $7,324,218.88 |
Aug. 17, 2021 | Director | 8,164 | $85.90 | Buy | $701,287.60 |
Aug. 13, 2021 | Director | 38,264 | $88.66 | Buy | $3,392,486.24 |
Aug. 11, 2021 | Director | 53,523 | $86.11 | Buy | $4,608,865.53 |
Sept. 24, 2020 | Director | 36,020 | $52.02 | Buy | $1,873,760.40 |
Sept. 22, 2020 | Director | 74,958 | $50.67 | Buy | $3,798,121.86 |
Sept. 8, 2020 | Director | 322,979 | $47.43 | Buy | $15,318,893.97 |
Sept. 3, 2020 | Director | 123,883 | $47.97 | Buy | $5,942,667.51 |
Aug. 21, 2020 | Director | 139,044 | $48.63 | Buy | $6,761,709.72 |
Aug. 19, 2020 | Director | 3,869 | $46.99 | Buy | $181,804.31 |
March 18, 2020 | Director | 150,000 | $38.18 | Buy | $5,727,000.00 |
March 16, 2020 | Director | 104,600 | $39.97 | Buy | $4,180,862.00 |
Feb. 26, 2020 | Director | 100,000 | $57.99 | Buy | $5,799,000.00 |
Feb. 24, 2020 | Director | 71,123 | $57.56 | Buy | $4,093,839.88 |
Dec. 6, 2019 | Director | 1,902,173 | $64.47 | Buy | $122,633,093.31 |
| Entrada Therapeutics Inc | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
June 6, 2022 | Major Shareholder | 38,304 | $6.41 | Buy | $245,528.64 |
June 2, 2022 | Major Shareholder | 2,643 | $5.82 | Buy | $15,382.26 |
May 23, 2022 | Major Shareholder | 7,837 | $5.99 | Buy | $46,943.63 |
May 20, 2022 | Major Shareholder | 16,849 | $5.84 | Buy | $98,398.16 |
May 18, 2022 | Major Shareholder | 34,433 | $6.00 | Buy | $206,598.00 |
May 16, 2022 | Major Shareholder | 19,000 | $5.83 | Buy | $110,770.00 |
| Incyte Corporation | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
March 10, 2022 | Director | 218,563 | $73.13 | Buy | $15,983,512.19 |
March 8, 2022 | Director | 100,000 | $70.67 | Buy | $7,067,000.00 |
Feb. 22, 2022 | Director | 99,800 | $68.07 | Buy | $6,793,386.00 |
Feb. 17, 2022 | Director | 292,972 | $67.74 | Buy | $19,845,923.28 |
Dec. 17, 2021 | Director | 1,075,872 | $72.80 | Buy | $78,323,481.60 |
Dec. 15, 2021 | Director | 350,332 | $71.51 | Buy | $25,052,241.32 |
May 28, 2020 | Director | 2 | $102.55 | Buy | $205.10 |
Sept. 8, 2017 | Director | 100,000 | $132.00 | Buy | $13,200,000.00 |
| Seagen Inc | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
Nov. 30, 2021 | Director | 301,444 | $160.33 | Sell | $48,330,516.52 |
May 8, 2020 | Director | 500,000 | $158.50 | Sell | $79,250,000.00 |
May 8, 2018 | Director | 460,651 | $53.34 | Buy | $24,571,124.34 |
May 4, 2018 | Director | 204,537 | $52.68 | Buy | $10,775,009.16 |
May 1, 2018 | Director | 306,917 | $51.36 | Buy | $15,763,257.12 |
Feb. 1, 2018 | Director | 3,846,153 | $52.00 | Buy | $199,999,956.00 |
| Talis Biomedical Corp | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
Nov. 18, 2021 | Director | 50,000 | $4.37 | Buy | $218,500.00 |
| BeiGene Ltd | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
Jan. 4, 2021 | Director | 121,154 | $220.50 | Sell | $26,714,457.00 |
Aug. 2, 2018 | Director | 5,814,100 | $108.00 | Buy | $627,922,800.00 |
Jan. 18, 2018 | Director | 1,980,198 | $101.00 | Buy | $199,999,998.00 |
Aug. 11, 2017 | Director | 176,056 | $71.00 | Buy | $12,499,976.00 |
Nov. 18, 2016 | Director | 1,760,495 | $32.00 | Buy | $56,335,840.00 |
Feb. 8, 2016 | Director | 1,912,680 | $24.00 | Buy | $45,904,320.00 |
| Hookipa Pharma Inc | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
April 23, 2019 | Insider | 892,857 | $14.00 | Buy | $12,499,998.00 |
| Kiniksa Pharmaceuticals Ltd | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
May 29, 2018 | Director | 3,000,000 | $18.00 | Buy | $54,000,000.00 |
| InVitae Corp | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
March 28, 2018 | Major Shareholder | 1,111,111 | $4.50 | Buy | $4,999,999.50 |
Nov. 17, 2016 | Major Shareholder | 733,333 | $6.00 | Buy | $4,399,998.00 |
| Bellicum Pharmaceuticals Inc | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
Jan. 19, 2018 | Major Shareholder | 880,735 | $8.20 | Sell | $7,222,027.00 |
Jan. 17, 2018 | Major Shareholder | 260,600 | $8.63 | Sell | $2,248,978.00 |
March 24, 2017 | Major Shareholder | 166,666 | $12.00 | Buy | $1,999,992.00 |
| Idera Pharmaceuticals Inc | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
Oct. 26, 2017 | Director | 8,000,000 | $1.50 | Buy | $12,000,000.00 |
| Rhythm Pharmaceuticals Inc | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
Oct. 5, 2017 | Insider | 885,000 | $17.00 | Buy | $15,045,000.00 |
| BioCryst Pharmaceuticals Inc | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
Aug. 16, 2016 | Major Shareholder | 4,046,590 | $5.00 | Sell | $20,232,950.00 |
Jan. 28, 2016 | major shareholder | 88,345 | $6.95 | Buy | $613,997.75 |
Jan. 22, 2016 | major shareholder | 106,800 | $7.28 | Buy | $777,504.00 |
Jan. 20, 2016 | major shareholder | 52,695 | $6.87 | Buy | $362,014.65 |
Jan. 19, 2016 | major shareholder | 92,200 | $7.12 | Buy | $656,464.00 |
Jan. 15, 2016 | major shareholder | 200,000 | $7.46 | Buy | $1,492,000.00 |
| Mirati Ther | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
June 9, 2016 | Major Shareholder | 999,358 | $9.41 | Sell | $9,403,958.78 |
Sept. 16, 2015 | Major Shareholder | 150,000 | $45.00 | Buy | $6,750,000.00 |
Jan. 29, 2015 | Major Shareholder | 425,000 | $20.00 | Buy | $8,500,000.00 |
| Intellia Therapeutics Inc | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
May 11, 2016 | Insider | 200,000 | $18.00 | Buy | $3,600,000.00 |
| XOMA Corp | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
July 22, 2015 | Insider | 11,000,000 | $1.09 | Sell | $11,990,000.00 |
Jan. 6, 2015 | Director | 2,215,400 | $3.81 | Sell | $8,440,674.00 |
Dec. 30, 2014 | Director | 744,000 | $3.67 | Sell | $2,730,480.00 |
Dec. 19, 2014 | Director | 1,605,100 | $4.26 | Sell | $6,837,726.00 |
Dec. 16, 2014 | Director | 1,033,800 | $4.46 | Sell | $4,610,748.00 |
Dec. 9, 2014 | Director | 392,353 | $4.62 | Sell | $1,812,670.86 |
Dec. 4, 2014 | Director | 2,372,206 | $4.79 | Sell | $11,362,866.74 |
Aug. 19, 2013 | Director | 2,757,791 | $3.62 | Buy | $9,983,203.42 |